Bone Biologics BBLG
NASDAQ BBLG
$0.50 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Bone Biologics (BBLG) Current Debt (2021)

Updated

Bone Biologics (BBLG) posted Current Debt of -$10,609 for FY2021, compared with $10,609 in FY2020.

Analysis

Bone Biologics (BBLG) Current Debt (2021) Analysis & Trends

  • Business Quant data shows BBLG's Current Debt at $10,609 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn -
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn 64.00 Mn
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn 1.93 Bn
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn -
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn 812.00 Mn
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn -
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn 1.68 Bn
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn -291.00 Mn
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn -
10 Bone Biologics 905,190.00 905,190.00 - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 -10,609.00
API Access

Bone Biologics Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=BBLG&period=max&api_key=YOUR_API_KEY